PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation
- First Posted Date
- 2009-06-22
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00925782
- Locations
- ๐บ๐ธ
University of Kansas Medical Center/University of Kansas Cancer Center and Medical Pavillion, Kansas City, Kansas, United States
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
- Conditions
- Interventions
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00722553
- Locations
- ๐บ๐ธ
University of Rochester Cancer Center, Rochester, New York, United States
๐บ๐ธPeachtree Hematology/Oncology Consultants, Atlanta, Georgia, United States
๐บ๐ธUniversity of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2007-11-07
- Last Posted Date
- 2020-01-03
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT00554827
- Locations
- ๐บ๐ธ
City of Hope National Medical Center, Duarte, California, United States
๐บ๐ธYale University School of Medicine, New Haven, Connecticut, United States
๐บ๐ธMemorial Sloan-Kettering Cancer Center, New York, New York, United States
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
- Conditions
- Interventions
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 119
- Registration Number
- NCT00481871
- Locations
- ๐บ๐ธ
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
๐บ๐ธFred Hutchinson Cancer Research Center, Seattle, Washington, United States
๐บ๐ธMemorial Sloan-Kettering Cancer Center, New York, New York, United States
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
- Conditions
- First Posted Date
- 2006-08-16
- Last Posted Date
- 2019-12-19
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT00364923
- Locations
- ๐จ๐ฆ
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
๐ง๐ชCliniques Universitaire Saint-Luc, Brussels, Belgium
๐บ๐ธCity of Hope National Medical Center, Duarte, California, United States
Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00144963
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
๐บ๐ธUniversity of Chicago Medical Center, Chicago, Illinois, United States
๐บ๐ธUniversity of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction
- Conditions
- Interventions
- First Posted Date
- 2005-09-05
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- Acrotech Biopharma Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT00145041
- Locations
- ๐บ๐ธ
University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States